ARCT opened at $17.12 on Friday. The stock has a market cap of $463.78 million, a PE ratio of -7.71 and a beta of 2.63. The business has a 50 day moving average of $17.28 and a 200-day moving ...
It's easy to use even if you don't consider yourself artistic, and even on the free tier, you get so many assets and design tools for creating logos for your business. For that reason, this free ...
We've been getting creative with the best logo makers for branding your business online. It's difficult to understate the importance of good logo design - it's the quickest way for customers and ...
What is the best career fit for me? Take our assessment now. Finding your dream job starts with knowing what makes you the way you are. Simple Statements that relate to you. Unique Be yourself ...
ARCT has been the subject of a number of research reports. HC Wainwright reaffirmed a “buy” rating and issued a $63.00 price objective on shares of Arcturus Therapeutics in a research note on ...
New York–based designer Amy Lau has passed away at the age of 56. Throughout her career, Lau managed to impact nearly every corner of the design industry—whether by creating dazzling spaces for both ...
However, one field has witnessed a significant transformation in the hands of AI designers. Artificial Intelligence in design is not just about replacing human designers; it enhances their abilities ...
ARCT-810 is under clinical development by Arcturus Therapeutics and currently in Phase II for Ornithine-Transcarbamylase Deficiency. According to GlobalData, Phase II drugs for ...
Wells Fargo analyst Yanan Zhu has maintained their bullish stance on ARCT stock, giving a Buy rating on January 15. Discover outperforming stocks and invest smarter with Top Smart Score Stocks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results